Not Tagged
Not Tagged
['rectal', 'prospect trial']
#asco23 plenary session underway with results of the prospect trial compared neoadjuvant crt vs folfox non-inferiority dfs was met path cr and qol similar neoadjuvant folfox, with selective use crt, is an effective tx for pts with ct2n+, ct3n-, or ct3n+ rectal cancer 
🩸 a podcast about heme/onc for health care providers | ☕️ short high yield episodes to supplement your board review resources | @SamArmstrongMD @DrKarineTawagi